Medication info
Elzelo Tablet 2 mg (Pitavastatin Calcium Hydrate)

Elzelo Tablet 2 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2.205mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Pink circular film-coated tablet with a line in the center
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201908040 · Approved 2019.11.22 · Insurance code 641907400

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Hypercholesterolemia
  • dyslipidemia
  • increased total cholesterol
  • increased LDL cholesterol
  • increased Apo-B protein
  • increased triglycerides
View approved original text

This medication helps to lower total cholesterol and bad LDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and also reduces triglycerides and Apo-B protein levels. It increases the levels of good cholesterol, HDL cholesterol, to support cardiovascular health. This drug is used as an adjunct therapy to improve blood lipid levels effectively when used in conjunction with dietary management.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be administered to certain patients. First, it should not be used in patients with an allergy to any of its ingredients or in patients with severe liver dysfunction, as well as in pregnant or potentially pregnant women, nursing mothers, and children. Additionally, patients taking cyclosporine or those with muscle diseases should not take this medication. Care must be taken when this medication is used in patients with liver and kidney dysfunction, those who consume alcohol excessively, the elderly, patients with hypothyroidism, and those with a history of muscle diseases. During treatment, symptoms such as muscle pain or weakness, liver function abnormalities, low platelet counts, rashes, or itching may occur, and if these symptoms develop, it is essential to consult a doctor immediately. Rarely, rhabdomyolysis, a condition characterized by muscle weakness or severe pain, may occur, and if muscle-related symptoms appear, the use of this medication should be discontinued immediately. Since this drug is mainly metabolized in the liver, regular liver function tests should be performed, and the treatment should be discontinued if liver function worsens. Moreover, taking this medication in conjunction with certain drugs (e.g., cyclosporine, fibrates, niacin, etc.) can lead to a rapid deterioration of kidney function; hence, they should be avoided or used with caution. The elderly may experience adverse reactions more easily due to declining physical function, so dosage adjustments may be necessary. Pregnant or breastfeeding women should not take this medication due to potential harm to the fetus or baby. This medication has not been confirmed for safety and efficacy in children, so it should not be used in this population. This medication contains lactose, so patients with lactose intolerance should avoid taking it. Store the medication in its original container and out of reach of children; transferring it to another container may cause accidents. Finally, consult a doctor before taking this medication to inform them of your health status and any other medications you are taking.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 79 more
  • liver function impairment
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • appetite loss
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • decreased granulocytes
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • increased serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • increased uric acid levels
  • elevated serum potassium and phosphorus
  • taste disturbances
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • severe muscle weakness
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • skin prickling
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is crucial to store it at room temperature, between 1 to 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

Pink circular film-coated tablet with a line in the center

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.